Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Filippo Russo
Observed names:
F Russo,
F. Russo
Institutions:
CEINGE Biotecnologie Avanzate Franco Salvatore (Italy),
University of Naples Federico II
Observed institutions:
National Cancer Institute,
CEINGE Biotecnologie Avanzate Franco Salvatore (Italy),
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale",
Candiolo Cancer Institute,
University of Naples Federico II
ORCID:
0000-0001-8128-9878
Observed ORCID:
0000-0001-8128-9878
OpenAlex ID:
A5016024062
RD‐CODOX‐M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and ‘unclassifiable’ highly aggressive B‐cell lymphoma
2011
·
Gaetano Corazzelli
, Ferdinando Frigeri
, et al.
·
British Journal of Haematology
·
86
Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma
2009
·
Gaetano Corazzelli
, Gaetana Capobianco
, et al.
·
Cancer Chemotherapy and Pharmacology
·
83
Biweekly rituximab, cyclophosphamide, vincristine, non‐pegylated liposome‐encapsulated doxorubicin and prednisone (R‐COMP‐14) in elderly patients with poor‐risk diffuse large B‐cell lymphoma and moderate to high ‘life threat’ impact cardiopathy
2011
·
Gaetano Corazzelli
, Ferdinando Frigeri
, et al.
·
British Journal of Haematology
·
64
PDF
Microbiome Profiling in Bladder Cancer Patients Using the First-morning Urine Sample
2023
·
Carmela Nardelli
, Achille Aveta
, et al.
·
European Urology Open Science
·
53
Gemcitabine, ifosfamide, oxaliplatin and rituximab (R-GIFOX), a new effective cytoreductive/mobilizing salvage regimen for relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a pilot study
2006
·
G. Corazzelli
, F. Russo
, et al.
·
Annals of Oncology
·
42
Hypoxic Pelvic Perfusion With Mitomycin C Using a Simplified Balloon-Occlusion Technique in the Treatment of Patients With Unresectable Locally Recurrent Rectal Cancer
2001
·
S. Guadagni
, G Fiorentini
, et al.
·
Archives of Surgery
·
38
Tandem high‐dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: A monocenter prospective study
2006
·
Luca Castagna
, Massimo Magagnoli
, et al.
·
American Journal of Hematology
·
35
Tumor flare reactions and response to lenalidomide in patients with refractory classic Hodgkin lymphoma
2009
·
Gaetano Corazzelli
, Rosaria De Filippi
, et al.
·
American Journal of Hematology
·
34
PDF
Pentostatin (2'-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomas.
2005
·
Gaetano Corazzelli
, Gaetana Capobianco
, et al.
·
PubMed
·
34
Expression of the Brain Transcription Factor OTX1 Occurs in a Subset of Normal Germinal-Center B Cells and in Aggressive Non-Hodgkin Lymphoma
2009
·
Daniela Omodei
, Dario Acampora
, et al.
·
American Journal Of Pathology
·
28
PDF
Deliberate hypoxic pelvic and limb chemoperfusion in the treatment of recurrent melanoma
2002
·
Stefano Guadagni
, Filippo Russo
, et al.
·
The American Journal of Surgery
·
21
Hepatitis C virus infection and new association with extrahepatic disease: multiple myeloma.
2000
·
M Montella
, A Crispo
, et al.
·
PubMed
·
20
Nasal Microbiome in COVID-19: A Potential Role of Corynebacterium in Anosmia
2022
·
Carmela Nardelli
, Giovanni Luca Scaglione
, et al.
·
Current Microbiology
·
19
PDF
Gastrointestinal adverse events of immunotherapy
2021
·
Giovanni Cappello
, Francesca Molea
, et al.
·
BJR|Open
·
18
Insights into Porphyromonas somerae in Bladder Cancer Patients: Urinary Detection by ddPCR
2024
·
Filippo Russo
, Speranza Esposito
, et al.
·
Microorganisms
·
16
PDF
Long-term follow-up study on the role of serum CA-125 as a prognostic factor in 221 newly diagnosed patients with Hodgkin's lymphoma
2007
·
Filippo Russo
, Secondo Lastoria
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
15
Gemcitabine, Ifosfamide, Oxaliplatin (GIFOX) as First-Line Treatment In High-Risk Peripheral T-Cell/NK Lymphomas: A Phase II Trial.
2010
·
Gaetano Corazzelli
, Ferdinando Frigeri
, et al.
·
Blood
·
13
Abnormally Elevated Levels of Serum Free-Immunoglobulin Light Chains Are Frequently Found in Classic Hodgkin Lymphoma (cHL) and Predict Outcome of Patients with Early Stage Disease.
2009
·
Rosaria De Filippi
, Filippo Russo
, et al.
·
Blood
·
13
A phase II study of dose‐dense and dose‐intense ABVD ( ABVD DD‐DI) without consolidation radiotherapy in patients with advanced H odgkin lymphoma
2014
·
Filippo Russo
, Gaetano Corazzelli
, et al.
·
British Journal of Haematology
·
12
Stop-flow in mediastinum and thorax for resistant lymphoma.
2000
·
S Guadagni
, F Russo
, et al.
·
PubMed
·
9
Genes of the “regulation of lymphocyte activation” pathway may influence immune cells infiltration in growth hormone secreting pituitary tumors
2025
·
Sabrina Chiloiro
, Flavia Costanza
, et al.
·
Pituitary
·
4
PDF
Dose-Dense(dd) ABVD and Dose-Dense/Dose-Intense(dd-di) ABVD in Newly Diagnosed Patients (pts), Intermediate- and Advanced-Stage with Classical Hodgkin's Lymphoma (cHL): Final Results.
2009
·
Filippo Russo
, Gaetano Corazzelli
, et al.
·
Blood
·
4
BCL10 expression and localization in ocular adnexa MALT lymphomas: a comparative cytogenetic and immunohistochemical study.
2014
·
Margherita Cerrone
, Francesca Collina
, et al.
·
PubMed
·
3
Gemcitabine, Ifosfamide, Oxaliplatin and Rituximab (R-GIFOX), a New Effective Cytoreductive/Mobilizing Salvage Regimen for Relapsed and Refractory Aggressive Non-Hodgkin’s Lymphoma: Results of a Pilot Study.
2005
·
Gaetano Corazzelli
, Filippo Russo
, et al.
·
Blood
·
3
Use of the cumulative amount of serum-free light chains (sFLC) at diagnosis and PET2 for the early identification of high risk of treatment failure in Hodgkin lymphoma (cHL).
2012
·
Rosaria De Filippi
, Fortunato Morabito
, et al.
·
Journal of Clinical Oncology
·
2
Show more works
View as search
Works count:
47
Citation count:
680
H-index:
15
I10-index:
19
Year
Topic
Type